RAPS recognizes that the current situation in Ukraine impacts our members and customers on many levels. If you are directly impacted by the current situation in the region and are challenged to meet your deadlines or obligations to RAPS, please reach out to raps@raps.org so that we can defer those challenges. Your health and safety are paramount to us.

Regulatory Focus™ > News Articles > Botanical Products: Drugs and Dietary Supplements

Botanical Products: Drugs and Dietary Supplements

Posted 01 August 2009

US regulations for botanical products that may be drugs can be confusing. In the author's experience, some botanicals that may have been processed and/or concentrated and have an indicated use for medical treatment are looked upon by the manufacturer as food supplements. Manufacturers take this position to avoid going through the rigors of the drug approval process. There are loopholes in the regulations that manufacturers try to use to eliminate this process.

 

© 2022 Regulatory Affairs Professionals Society.

Regulatory Focus newsletters

All the biggest regulatory news and happenings.

Subscribe